Live news related to MEDINCELL stock (FR0004065605): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
Medincell announces the participation of Christophe Douat and Richard Malamut at the Jefferies London Global Healthcare Conference on November 18, 202…
The share price of the French biopharmaceutical company Medincell records a rise of 4.41% this Wednesday, November 12, at mid-day, reaching 31.28 euro…
Medincell, specializing in long-acting injectable drugs, has announced strategic changes within its leadership.
Medincell stock began its recovery this Tuesday morning, regaining ground after a week marked by commercial disappointments. The Montpellier-based bio…
MEDINCELL closed Monday at 29.48 euros, down 6.71% from the previous close. This correction follows a rally of 84.48% over the past three months. The …
Medincell has been selected to join the MSCI World Small Cap Index starting November 24, 2025, according to the company's press release.
MEDINCELL's stock accelerates its decline on Thursday. The French biotech suffers a second consecutive day of significant losses following Wednesday's…
Medincell, a biopharmaceutical company based in Montpellier, announces that its executives will participate in two investor conferences scheduled for …
Medincell announces, through its partner Teva Pharmaceuticals, significant advancements in the development of a monthly subcutaneous olanzapine inject…
Medincell enjoyed a strong trading day on Tuesday, closing up 2.28%. The stock is experiencing a remarkable performance period, propelling it to unpre…
